AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people,…
Boehringer Ingelheim develops and produces pharmaceutical products for humans and animals, having starting operating in Greece in 1966. Boehringer Ingelheim Hellas is a leading pharmaceuticals manufacturer and exporter in Greece.
Bristol-Meyer Squibb is a pharmaceutical company based in the USA with offices in Greece. They manufacture prescriptions for the treatment of cancer, diabetes, hepatitis, and more.
Demo is one of the top pharmaceutical companies in Greece. Demo manages both the production and sale of their pharmaceutical products and is listed among the Top 100 in Greek Industries.
Elpen is a leading Greek pharmaceutical company, specialised in the production of branded generics, with a presence in more than 60 countries.
GAP Pharmaceuticals is one of the leading pharmaceutical manufacturers in Greece. Established in 1949, GAP produces both generic and new pharmaceutical products, manufactures soft capsules, and distributes their EVIOL products.
Genepharm is a pharmaceutical company focused specifically on producing and distributing generic medications.
Janssen is a subsidiary of Johnson & Johnson and is one of the leading pharmaceutical companies in Greece.
Johnson & Johnson is a leading pharmaceutical company and producer of health and beauty products. Its Greek offices were established in 1975.
Merck A.E. Hellas is a top pharmaceutical and technology company. In Greece, Merck Hellas specifically focuses on the fields of healthcare and biopharma, along with life sciences.
MSD is a pharmaceutical company that creates products to treat infectious diseases, diabetes, and infertility, among others.
Pfizer Hellas is the Greek subsidiary of international pharmaceutical company Pfizer.
Pharmathen is a pharmaceutical company that produces generic medications. Pharmathen was established in Greece but is now headquartered in the Netherlands. The company operates two manufacturing sites in Athens and Thessaloniki and a research and…
Piefasyn markets and distributes pharmaceutical products.
Power Health was one of the first pharmaceutical companies in Greece to focus solely on producing alternative, holistic health products.
With over 150 pharmaceutical products, Rafarm is one of Greece’s top five pharmaceutical companies.
Roche established branches in Greece in the 1930s and today operates both Roche (Hellas) S.A., the pharmaceutical arm, and Roche Diagnostics (Hellas) S.A., which creates diagnostic products for laboratories.
Vianex is a leading pharmaceutical company and exporter in Greece with headquarters in Athens and Thessaloniki, as well as manufacturing plants across the country.
Greece Investor Guide
A daily dose of news and trends about the Greek economy & highlights of business and investment opportunities.
#Greece #Greek #invest #GreekEconomy
Greece’s Organisation for Economic Co-operation and Development (OECD) anticipates that Greece will end 2022 with 6.7% growth 📈, and estimates that recent efforts by the government will help to recover the country’s investment grade. In particular, the tourism sector’s recovery
In another major boost for Greece’s infrastructure, 2 railway projects 🚃 amounting to over €200 million are getting underway, signaling the development of key infrastructure upgrades to the country’s railway network. One of these projects is the Rhododafni - Rio project,
Greek start-up Blueground has had an excellent year, raising $180 million 💶 with $140 million from financing via a share capital increase from investment companies including WestCap, Geolo Capital, Prime Ventures and the Greek fund VentureFriends. The company has a presence
Greece’s cosmetics 💄 exports are set to break records, possibly reaching €500 million by the end of the year! According to data from ELSTAT, processed by the organization Enterprise Greece, Cyprus, the U.K., and France are believed to be key destinations in the coming 5 years.
Changes are on the way for Mykonos’ tourism industry 🏝️! The Greek state has announced plans to subsidise the creation of a 192-bed hotel developed by AGC Equity Partners, providing €6.6 million in the form of tax exemptions. The total amount of this project lands
Greece Investor Guide (GIG) and the producer of GIG are not registered investment or legal or tax advisors or brokers/dealers. All investment and/or financial opinions expressed within GIG are based on the personal research and experience of GIG's editorial team, as well as on interviews conducted with key players within or associated with the Greek economy. The content of GIG is intended to be used, and must be used, for informational and educational purposes only. You must take independent financial and/or any other professional advice from an expert and/or a professional, and/or you must make independent research and verify any information that you find within GIG and wish to rely upon, whether for the purpose of making an investment decision or otherwise.
Although best efforts are made to ensure that all information is accurate and up to date, unintended errors and/or misprints and/or omissions may occur. The producer of GIG shall not be held responsible for any such errors and/or misprints and/or omissions. The producer of GIG shall not, in any circumstances (a) be legally bound as a result of any information contained in this guide or (b) be held responsible for any losses or liabilities that may arise in respect of such information or for any use of such information by any such person.
All rights reserved. Reproduction in whole or in part is strictly prohibited without written permission.